FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadj…
This meeting is not an official program of the ASCO Annual
British Journal of Cancer – Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Olaparib, durvalumab, and fulvestrant produced a 66.7% 24-week PFS rate in patients with endocrine-resistant ER-positive, HER2-negative breast cancer.
Social media provides a vibrant channel for connection and collaboration with the global oncology community during ASCO24. Follow along for live updates on key research…
The FDA has granted accelerated approval to lisocabtagene maraleucel for the treatment of select adult patients with relapsed or refractory follicular lymphoma.
Researchers also find lack of fresh fruit and vegetables in schools and say portion sizes sometimes not enough
An inadequate response to the deep problems within the NHS? Winter is not yet fully upon us and already emergency departments in the UK are…
Failure is a key feature of innovation and learning from innovation failure has been seen as the main source of knowledge production and future succes…
The effort stems from the industry’s skepticism that the Trump campaign will be able to focus on energy issues as election day draws closer.